Allergy alerting and overrides for opioid analogues across two health systems
We evaluated overrides of opioids and used this data to suggest ways to redesign DAAs to decrease alert override rates, combat alert fatigue and improve patient safety.
Authors
- Li Zhou (ORCID: https://orcid.org/0000-0003-3874-4833)
- Diane L. Seger (ORCID: https://orcid.org/0000-0001-9924-378X)
- David W. Bates (ORCID: https://orcid.org/0000-0001-6268-1540)
- Kimberly G. Blumenthal (ORCID: https://orcid.org/0000-0003-4773-9817)
- Foster Goss (ORCID: https://orcid.org/0000-0002-7939-7885)
- Ying-Chih Lo (ORCID: https://orcid.org/0000-0001-6538-842X)
- Heba H Edrees (ORCID: https://orcid.org/0000-0001-7337-1046)
- Suzanne V. Blackley
- Sheril Varghese (ORCID: https://orcid.org/0009-0002-7930-4623)
- Liqin Wang (ORCID: https://orcid.org/0000-0002-8280-8892)
- Rachel L Wasserman
Institutions
- Political Research Associates (US)
- Brigham and Women's Hospital (US)
- Harvard University (US)
- Massachusetts College of Pharmacy and Health Sciences (US)
- University of Colorado Denver (US)
Publication Details
- Journal
- BMJ Health & Care Informatics
- Published
- 2025-05-01
- DOI
- https://doi.org/10.1136/bmjhci-2024-101259
- Primary Topic
- Drug-Induced Adverse Reactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Agency for Healthcare Research and Quality